Evidence map›Paper›PMID 40350449›Full record

ArticleScientific reports2025

A gelable polymer loaded with curcumin and apatinib absorbed in gelatin sponge delays postoperative residual tumor growth.

Zhuo-Nan Meng, Jian-Yuan Chen, Chong Yu, Ai-Hong Zheng, O Sreekanth Reddy, Kai-Yan Liu, Yong-Rui Su, Shi-Tai Zhang, Yin-Shuang Wang, Hang-Yu Gu and 7 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Zhuo-Nan Meng *The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Jian-Yuan Chen *The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Chong YuDepartment of Urology, Urology & Nephrology Center, Zhejiang Provincial People'sHospital, Affiliated People's Hospital, Hangzhou Medical College, No. 138 ShangTang Road, Hangzhou, 310014, China.
Ai-Hong ZhengDepartment of Medical Oncology, Cancer Center, Zhejiang Provincial People's Hospital(Affiliated People's Hospital, Hangzhou Medical College), No. 138 ShangTang Road, Hangzhou, 310014, China.
O Sreekanth ReddyDepartment of Urology, Urology & Nephrology Center, Zhejiang Provincial People'sHospital, Affiliated People's Hospital, Hangzhou Medical College, No. 138 ShangTang Road, Hangzhou, 310014, China.
Kai-Yan LiuDepartment of Urology, Urology & Nephrology Center, Zhejiang Provincial People'sHospital, Affiliated People's Hospital, Hangzhou Medical College, No. 138 ShangTang Road, Hangzhou, 310014, China.
Yong-Rui SuThe Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Shi-Tai ZhangThe Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Yin-Shuang WangDepartment of Ultrasound Medicine, The First Affiliated Hospital of Ningbo University, Ningbo, 315010, Zhejiang Province, China.
Hang-Yu GuDepartment of Oncology and Hematology, Beilun District People's Hospital, Ningbo, China.
Fu-Wei WangDepartment of Medical Oncology, Cancer Center, Zhejiang Provincial People's Hospital(Affiliated People's Hospital, Hangzhou Medical College), No. 138 ShangTang Road, Hangzhou, 310014, China.
Song-Cheng XuDepartment of Ultrasound, Zhejiang Provincial People's Hospital (Affiliated People'sHospital, Hangzhou Medical College), No. 138 ShangTang Road, Hangzhou, 310014, China.
Li-Tao SunDepartment of Ultrasound, Zhejiang Provincial People's Hospital (Affiliated People'sHospital, Hangzhou Medical College), No. 138 ShangTang Road, Hangzhou, 310014, China.
Bing-Chen ChenDepartment of Anal Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, China.
Wing-Fu LaiDepartment of Urology, Urology & Nephrology Center, Zhejiang Provincial People'sHospital, Affiliated People's Hospital, Hangzhou Medical College, No. 138 ShangTang Road, Hangzhou, 310014, China. rori0610@graduate.hku.hk.
Guo-Qing WuDepartment of Medical Oncology, Cancer Center, Zhejiang Provincial People's Hospital(Affiliated People's Hospital, Hangzhou Medical College), No. 138 ShangTang Road, Hangzhou, 310014, China. gqwuzsu@hotmail.com.
Da-Hong ZhangDepartment of Urology, Urology & Nephrology Center, Zhejiang Provincial People'sHospital, Affiliated People's Hospital, Hangzhou Medical College, No. 138 ShangTang Road, Hangzhou, 310014, China. zhangdahong168@163.com.

Funding

Science and Technology Program with Traditional Chinese Medicine of Zhejiang Province 2023ZL271Science and Technology Program with Traditional Chinese Medicine of Zhejiang Province 2024ZL286Scientific Research Foundation of the Education Department of Zhejiang Province Y202249375
6 · The paper itself

Abstract

Surgical resection of the tumor remains the preferred treatment for most solid tumors at an early stage, however, residual tumor cells after surgical resection poses a considerable obstacle in cancer treatment. Here, we developed a gel carrier using a cellulose-based gel-forming polymer (CT) combined with gelatin sponge (GS) to fill the resection cavity and delay postoperative residual tumor growth. The fabricated gel exhibited a porous nature along with gradual swelling and erosion over time. Curcumin (Cur) and apatinib (Apa) were loaded into CT gel (CT-CA), and a sustained release behavior was observed at pH 7.4 and 6.4 at 37 °C. The preclinical studies indicated that the mouse weight and tissue exhibited no apparent change after administration of the GS-CT compared with the control. The in vivo fluorescence images showed that GS-CT has the capability to regulate the release of Cur and Apa, facilitating the accumulation of these two agents at the surgical tumor site. Moreover, GS-CT loaded Cur and Apa (GS-CT-CA) delayed postoperative residual tumor growth in intraperitoneal and subcutaneous postoperative mouse models. These findings demonstrated that our gel carrier system significantly prevents postoperative residual tumor growth because of enhanced drug accumulation and sustained drug release at the tumor site.

Indexed as

Antineoplastic AgentsCurcuminGelatin Sponge, AbsorbableNeoplasm, ResidualPolymersPyridinesAnimalsCell Line, TumorDrug CarriersDrug LiberationGelatinGelsHumansMiceAntineoplastic AgentsapatinibCurcuminDrug CarriersGelatinGelsPolymersPyridinesApatinibCurcuminGelatin spongeGel-forming polymerPostoperative residual tumor

Identifiers

PMID40350449
PMCPMC12066724

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.